SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.
NewAtlas | New research has found that patients taking the weight-loss and diabetes drug semaglutide had significantly reduced symptoms of alcohol use disorder. Although the study was small, larger st